Use of L-arginine and its analogs to study nitric oxide pathway in humans

Methods in Enzymology

Volumn 269, Issue , 1996, Pages 453-459

  Vallance, Patrick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININE DERIVATIVE; CITRULLINE; FREE RADICAL; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CARDIOVASCULAR SYSTEM; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 7; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029839686     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0076-6879(96)69046-6     Document Type: Article

References (26)

1. P. Vallance and S. Moncada, J. R. Coll. Physicians 28, 209 (1994).
2. A. Calver, J. Collier, and P. Vallance, Exp. Physiol. 78, 303 (1993).
3. N. Benjamin, A. Calver, J. Collier, B. Robinson, P. Vallance, and D. Webb, Hypertension (Dallas) 25, 918 (1995).
4. O. W. Griffith and R. G. Kilbourn, Methods Enzymol. 268, 375 (1996).
5. N. M. Olken, K. M. Rusche, M. K. Richards, and M. A. Marletta, Biochem. Biophys. Res. Commun. 177, 828 (1991).
6. R. J. MacAllister, G. StJ. Whitley, and P. Vallance, Kidney Int. 45, 737 (1994).
7. R. F. Furchgott, D. Jothianandan, and A. D. Freay, in "Nitric Oxide from L-Arginine: A Bioregulatory System" (S. Moncada and E. A. Higgs, eds.), p. 5. Elsevier Amsterdam, 1990.
8. J. Rajfer, W. J. Aronson, P. A. Bush, F. J. Dorey, and L. J. Ignarro, N. Engl. J. Med. 326, 90 (1992).
9. P. Vallance, J. Collier, and S. Moncada, Lancet 2, 997 (1989).
10. P. Vallance, J. Collier, and S. Moncada, Cardiovasc. Res. 23, 1053 (1989).
11. J. Collier and P. Vallance, J. Cardiovasc. Pharmacol. 17, 182 (1991).
12. W. G. Haynes, J. P. Noon, B. R. Walker, and D. J. Webb, J. Hypertens. 11, 1375 (1993).
13. J. S. Stamler, E. Loh, M. A. Roddy, K. E. Currie, and M. A. Creager, Circulation 89, 2035 (1994).
14. D. C. Lefroy, T. Crake, N. G. Uren, G. J. Davies, and A. Maseri, Circulation 88, 43 (1993).
15. G. R. May, P. Crook, P. K. Moore, and C. P. page, Br. J. Pharmacol. 102, 759 (1991).
16. D. I. Simon, J. S. Stamler, E. Loh, J. Loscalzo, and M. A. Creager, Clin. Res. 41, 117A (1993).
17. P. Vallance, N. Benjamin, and J. Collier, Eur. J. Clin. Pharmacol. 42, 37 (1992).
18. S. Fickling, A. Leone, S. Nussey, P. Vallance, and G. Whitley, Endothelium 1, 137 (1993).
19. J. R. McDermott, Biochem. J. 154, 179 (1976).
20. R. MacAllister, G. Whitley, and P. Vallance, Br. J. Pharmacol. 112, 43 (1994).
21. J. L. Buxton, D. J. Cheek, D. Eckman, D. P. Westfall, K. M. Sanders, and K. D. Keef, Circ. Res. 72, 387 (1993).
22. R. G. Tilton, C. Chang, K. S. Hasan, S. R. Smith, M. J. Petrash, T. P. Misko, W. M. Moore, M. G. Currie, J. A. Corbett, M. L. McDaniel, and J. R. Williamson, Diabetes 42, 221 (1993).
23. T. Nakaki, K. Hishikawa, H. Suzuki, T. Saruta, and R. Kato, Lancet 336, 696 (1990).
24. R. MacAllister, B. Herreros, S. S. Nussey, J. Collier, and P. Vallance, Clin. Sci. 89, 183 (1995).
25. A. L. Calver, J. Collier, and P. Vallance, Clin. Sci. 81, 695 (1991).
26. A. L. Calver, J. G. Collier, S. Moncada, and P. J. T. Vallance, J. Hypertens. 10, 1025 (1992).